person

Niloefar A. B.

Country
Belgium
Department
Nuclear Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 1 partner site.

Specializations

Oncology & Hematologic Malignancies

Research activities include therapeutic evaluation of solid tumors and hematologic malignancies across multiple organ systems.

  • Advanced breast cancer
  • Non‑small cell lung cancer
  • Colorectal cancer
  • Hodgkin and non‑Hodgkin lymphoma
  • Multiple myeloma
  • Acute myeloid leukemia
  • Renal cell carcinoma

Collaboration with the nuclear medicine division enables imaging‑guided assessment of targeted therapies.

Autoimmune & Inflammatory Disorders

The investigator contributes to trials addressing systemic immune‑mediated conditions.

  • Systemic lupus erythematosus
  • Myasthenia gravis
  • Rheumatoid arthritis
  • Inflammatory bowel disease (Crohn's disease, ulcerative colitis)
  • Psoriasis
  • Hidradenitis suppurativa
  • Vasculitis

Studies often incorporate biomarker analysis to elucidate disease mechanisms.

Neurological & Neurodegenerative Diseases

Clinical investigations focus on progressive disorders of the central and peripheral nervous systems.

  • Amyotrophic lateral sclerosis
  • Alzheimer's disease
  • Parkinson's disease
  • Frontotemporal dementia
  • Multiple sclerosis
  • Epilepsy
  • Neuroblastoma

Imaging biomarkers are leveraged to monitor disease progression and therapeutic response.

Cardiovascular, Metabolic & Renal Diseases

Investigations span disorders of the heart, vasculature, metabolism, and kidney function.

  • Atrial fibrillation
  • Heart failure
  • Atherosclerotic cardiovascular disease
  • Obesity and type 2 diabetes
  • Chronic kidney disease
  • Proteinuric kidney disease
  • Hypertension

Therapeutic strategies often target metabolic pathways and vascular health.

Pulmonary & Infectious Diseases

Research includes respiratory conditions and infectious agents affecting the lung.

  • Non‑tuberculous mycobacterial infection
  • Chronic obstructive pulmonary disease
  • Interstitial lung disease
  • Bronchiectasis
  • COVID‑19
  • Pulmonary arterial hypertension
  • Fungal lung infections

Imaging techniques are employed to quantify disease burden and therapeutic impact.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.